{
    "2021-09-02": [
        [
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：静注COVID-19人免疫球蛋白(pH4)获批开展临床试验",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "静注COVID-19人免疫球蛋白",
                        "pH4",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：所属公司获批开展“静注 COVID-19 人免疫球蛋白（pH4）”临床试验",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "静注COVID-19人免疫球蛋白",
                        "pH4",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：所属企业获准开展“静注COVID-19人免疫球蛋白（pH4）”临床试验",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "静注COVID-19人免疫球蛋白",
                        "pH4",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}